← Evidence map

ArticleCell death & disease2021

Rosuvastatin protects against coronary microembolization-induced cardiac injury via inhibiting NLRP3 inflammasome activation.

Ao Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

35 papers cite it

2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33436548